A correlation analysis with the clinical outcome of CRC patients revealed that high levels of α6 integrin, E-cadherin, and their coexpression in liver metastases were all associated with shorter disease-free survival after surgical intervention (Fig 10). The gene discussed is CDH1; the disease is colorectal carcinoma.